Literature DB >> 26704184

Production of CCL20 on nucleus pulposus cells recruits IL-17-producing cells to degenerated IVD tissues in rat models.

Yuanqiang Zhang1, Lian Liu1, Shuaishuai Wang1, Yunpeng Zhao1, Yi Liu1, Jingkun Li1, Lin Nie1, Lei Cheng2.   

Abstract

IL-17-producing cells play an important role in various autoimmune diseases. A higher level of IL-17-producing cells is observed in patients with intervertebral disc (IVD) degeneration. However, the mechanism of the accumulation of IL-17-producing cells remains to be elucidated. Our aim is to demonstrate whether the interaction of CC chemokine ligand (CCL) 20 and its specific receptor CCR6 is involved in the recruitment of IL-17-producing cells to degenerated disc tissues in rat models. The well-accepted needle puncture model and the autologous nucleus pulposus application model of rats were established. All of the animals were randomly divided into four groups: the sham surgery group, the needle puncture group (NP group), the sham surgery + autologous nucleus pulposus application group (sham-ANPA group) and the needle puncture + autologous nucleus pulposus application group (NP-ANPA group). Immunohistochemical staining, western blot and real-time PCR were used to evaluate the expression levels of CCL20, IL-17 and CCR6 in the IVD samples. Moreover, the IL-17 concentrations in the serum were detected by ELISA. Pearson correlations were performed to analyse the correlation among the expressions of CCL20, CCR6 and IL-17. The expressions of CCL20, IL17 and CCR6 were dramatically elevated in comparison with the control groups. The circulating IL-17 in the serum of the NP-ANPA group was elevated compared to the sham surgery group. In addition, there was a positive correlation among the expression levels of CCL20, CCR6 and IL-17. The results suggest a potential mechanism for the recruitment of IL-17-producing cells to degenerated intervertebral discs via a CCL20/CCR6 system in vivo.

Entities:  

Keywords:  CC chemokine ligand 20; CC chemokine receptor 6; Degenerated intervertebral discs; Interleukin-17; Nucleus pulposus; Rats

Mesh:

Substances:

Year:  2015        PMID: 26704184     DOI: 10.1007/s10735-015-9651-2

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  33 in total

Review 1.  Role of cytokines in intervertebral disc degeneration: pain and disc content.

Authors:  Makarand V Risbud; Irving M Shapiro
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

Review 2.  T(H)-17 cells in the circle of immunity and autoimmunity.

Authors:  Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2007-04       Impact factor: 25.606

3.  Risk factors in low-back pain. An epidemiological survey.

Authors:  J W Frymoyer; M H Pope; J H Clements; D G Wilder; B MacPherson; T Ashikaga
Journal:  J Bone Joint Surg Am       Date:  1983-02       Impact factor: 5.284

4.  Cytokine evaluation in individuals with low back pain using discographic lavage.

Authors:  Jason M Cuellar; S Raymond Golish; Merrill W Reuter; Vanessa G Cuellar; Martin S Angst; Eugene J Carragee; David C Yeomans; Gaetano J Scuderi
Journal:  Spine J       Date:  2010-03       Impact factor: 4.166

5.  The effect of repeated restraint stress in pain-related behavior induced by nucleus pulposus applied on the nerve root in rats.

Authors:  Kazuhide Uesugi; Miho Sekiguchi; Shin-ichi Kikuchi; Shin-ichi Konno
Journal:  Eur Spine J       Date:  2011-06-23       Impact factor: 3.134

6.  CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups.

Authors:  Gina Lisignoli; Cristina Manferdini; Katia Codeluppi; Anna Piacentini; Francesco Grassi; Luca Cattini; Giuseppe Filardo; Andrea Facchini
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

7.  Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.

Authors:  Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

8.  Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.

Authors:  Satya P Singh; Hongwei H Zhang; John F Foley; Michael N Hedrick; Joshua M Farber
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

9.  The pattern of interleukin-12 and T-helper types 1 and 2 cytokine expression in herniated lumbar disc tissue.

Authors:  Jong-Beom Park; Han Chang; Yong-Sik Kim
Journal:  Spine (Phila Pa 1976)       Date:  2002-10-01       Impact factor: 3.468

10.  Selection of reference genes for normalization of quantitative real-time PCR in organ culture of the rat and rabbit intervertebral disc.

Authors:  Dongrim Seol; Hyeonghun Choe; Hongjun Zheng; Keewoong Jang; Prem S Ramakrishnan; Tae-Hong Lim; James A Martin
Journal:  BMC Res Notes       Date:  2011-05-26
View more
  10 in total

Review 1.  Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration.

Authors:  Yizhong Peng; Xiangcheng Qing; Hongyang Shu; Shuo Tian; Wenbo Yang; Songfeng Chen; Hui Lin; Xiao Lv; Lei Zhao; Xi Chen; Feifei Pu; Donghua Huang; Xu Cao; Zengwu Shao
Journal:  Biomater Transl       Date:  2021-06-28

Review 2.  New Progress in Basic Research of Macrophages in the Pathogenesis and Treatment of Low Back Pain.

Authors:  Miaoheng Yan; Zongmian Song; Hongwei Kou; Guowei Shang; Chunfeng Shang; Xiangrong Chen; Yanhui Ji; Deming Bao; Tian Cheng; Jinfeng Li; Xiao Lv; Hongjian Liu; Songfeng Chen
Journal:  Front Cell Dev Biol       Date:  2022-05-20

3.  Intervertebral Disc Degeneration in a Percutaneous Mouse Tail Injury Model.

Authors:  Zuozhen Tian; Xiaoyuan Ma; Miersalijiang Yasen; Robert L Mauck; Ling Qin; Frances S Shofer; Lachlan J Smith; Maurizio Pacifici; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Am J Phys Med Rehabil       Date:  2018-03       Impact factor: 2.159

4.  Influence of Genetic Background and Sex on Gene Expression in the Mouse (Mus musculus) Tail in a Model of Intervertebral Disc Injury.

Authors:  Julie M Brent; Zuozhen Tian; Frances S Shofer; John T Martin; Lutian Yao; Christian Acharte; Youhai H Chen; Ling Qin; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Comp Med       Date:  2020-03-10       Impact factor: 0.982

5.  Progranulin Is Positively Associated with Intervertebral Disc Degeneration by Interaction with IL-10 and IL-17 Through TNF Pathways.

Authors:  Shaoyi Wang; Jianlu Wei; Yuchen Fan; Hong Ding; Huichao Tian; Xiaocong Zhou; Lei Cheng
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

6.  Progranulin derived engineered protein Atsttrin suppresses TNF-α-mediated inflammation in intervertebral disc degenerative disease.

Authors:  Hong Ding; Jianlu Wei; Yunpeng Zhao; Yi Liu; Lian Liu; Lei Cheng
Journal:  Oncotarget       Date:  2017-11-29

7.  Follistatin-like protein 1 promotes inflammatory reactions in nucleus pulposus cells by interacting with the MAPK and NFκB signaling pathways.

Authors:  Yi Liu; Jianlu Wei; Yunpeng Zhao; Yuanqiang Zhang; Yingguang Han; Bin Chen; Kaiyuan Cheng; Jialin Jia; Lin Nie; Lei Cheng
Journal:  Oncotarget       Date:  2017-06-27

8.  Carthamin yellow inhibits matrix degradation and inflammation induced by LPS in the intervertebral disc via suppression of MAPK pathway activation.

Authors:  Bin Chen; Han-Tao Wang; Bo Yu; Ji-Dong Zhang; Yu Feng
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

Review 9.  The Role of IL-17-Mediated Inflammatory Processes in the Pathogenesis of Intervertebral Disc Degeneration and Herniation: A Comprehensive Review.

Authors:  Kaori Suyama; Daisuke Sakai; Masahiko Watanabe
Journal:  Front Cell Dev Biol       Date:  2022-03-03

10.  Acupuncture in the Treatment of Sequestered Intervertebral Disk Herniation.

Authors:  Vadim Buevich; Maxim Buevich; Natalia Buevich
Journal:  Med Acupunct       Date:  2021-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.